Cite
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study
MLA
Chan Soon Park, et al. “Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): A Prospective Randomized, Open-Label, Multicenter Study.” Cardiovascular Drugs and Therapy, vol. 37, Jan. 2022, pp. 529–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58d4cc6d196827394e3c16bd68565118&authtype=sso&custid=ns315887.
APA
Chan Soon Park, Jin Joo Park, Hae-Young Lee, Seok-Min Kang, Byung-Su Yoo, Eun-Seok Jeon, Suk Keun Hong, Joon-Han Shin, Myung-A. Kim, Dae-Gyun Park, Eung-ju Kim, Soon-jun Hong, Seok Yeon Kim, Jae-Joong Kim, & Dong-Ju Choi. (2022). Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study. Cardiovascular Drugs and Therapy, 37, 529–537.
Chicago
Chan Soon Park, Jin Joo Park, Hae-Young Lee, Seok-Min Kang, Byung-Su Yoo, Eun-Seok Jeon, Suk Keun Hong, et al. 2022. “Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): A Prospective Randomized, Open-Label, Multicenter Study.” Cardiovascular Drugs and Therapy 37 (January): 529–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58d4cc6d196827394e3c16bd68565118&authtype=sso&custid=ns315887.